Clinical Considerations in the Management of NF1-Associated Inoperable Plexiform Neurofibromas and Case Discussion

Download these slides from a live symposium for a review of clinical considerations in the management of inoperable plexiform neurofibromas in patients with NF1 and case presentations.
Carlos Romo, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 226 KB
Released: June 20, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Alexion Pharmaceuticals

Related Content

Experts discuss current and emerging targeted therapies and clinical considerations in the treatment of NF1 and inoperable plexiform neurofibromas, from Clinical Care Options (CCO)

person default Miriam Bornhorst, MD Carlos Romo, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: July 8, 2022 Expired: July 7, 2023

Downloadable slideset covering targeted therapy in inoperable plexiform neurofibromas in patients with NF1, from Clinical Care Options (CCO)

person default Miriam Bornhorst, MD Released: June 20, 2022

Focused, expert-authored module from Clinical Care Options (CCO): Drs Stephen Liu and Ryma Benayed discuss NRG1 testing and treatment strategies for NRG1 fusion positive cancers

person default Ryma Benayed, PhD Stephen V. Liu, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: February 2, 2022 Expired: February 1, 2023

Short slideset on second-generation TRK inhibitors selitrectinib and repotrectinib in NTRK fusion+ solid tumors, from Clinical Care Options (CCO)

George D. Demetri, MD Alexander Drilon, MD Released: November 9, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings